STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Solventum (SOLV) legal officer settles 3,811 RSUs, disposes 1,510 shares for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Solventum Corp’s Chief Legal Affairs Officer reported routine equity transactions in company stock. On 12/01/2025, the officer exercised 3,811 restricted stock units, receiving the same number of Solventum common shares as they fully vested. To cover tax obligations, 1,510 shares were disposed of at a price of $85.56 per share. After these transactions, the officer directly owned 8,056 shares of Solventum common stock. These transactions were reported on a Form 4 as a single‑person filing.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kirberger Marcela A.

(Last) (First) (Middle)
2510 CONWAY AVENUE EAST
3M CENTER, BUILDING 275-6W

(Street)
MAPLEWOOD MN 55144

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Affairs Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/01/2025 M 3,811 A (1) 9,566 D
Common Stock 12/01/2025 F 1,510 D $85.56 8,056 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 12/01/2025 M 3,811 (2) 12/01/2025 Common Stock 3,811 $0 0(2) D
Explanation of Responses:
1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
2. The RSUs are fully vested.
Remarks:
/s/Matthew Rice, attorney-in-fact for Marcela Kirberger 12/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Solventum (SOLV) disclose in this Form 4?

The filing discloses that Solventum’s Chief Legal Affairs Officer exercised 3,811 restricted stock units on 12/01/2025, receiving the same number of common shares, and disposed of 1,510 shares to cover taxes.

Who is the reporting person in the Solventum (SOLV) Form 4 filing?

The reporting person is an officer of Solventum Corp, serving as the Chief Legal Affairs Officer, filing individually rather than as part of a group.

How many Solventum (SOLV) shares does the officer own after the reported transactions?

Following the reported transactions on 12/01/2025, the officer directly owns 8,056 shares of Solventum common stock.

What happened to the restricted stock units reported by Solventum (SOLV)?

The filing states that each restricted stock unit (RSU) represents a right to receive one share of common stock upon settlement, and the 3,811 RSUs involved were fully vested and settled into shares at an exercise price of $0.

Why were some Solventum (SOLV) shares sold or withheld in this Form 4?

The Form 4 shows 1,510 shares of Solventum common stock disposed of at $85.56 per share using transaction code F, which indicates shares withheld or sold to satisfy tax withholding obligations.

Is this Solventum (SOLV) Form 4 filing related to a Rule 10b5-1 trading plan?

The form includes a checkbox to indicate if transactions were made under a Rule 10b5-1(c) trading plan, but the excerpt does not show that this box was checked as part of the reported information.

Solventum Corporation

NYSE:SOLV

SOLV Rankings

SOLV Latest News

SOLV Latest SEC Filings

SOLV Stock Data

14.79B
147.58M
14.9%
66.72%
2.46%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
ST. PAUL